Growth Metrics

Adagio Medical Holdings (ADGM) Debt to Equity (2023)

Adagio Medical Holdings (ADGM) reported Debt to Equity of -$0.01 for Q4 2023.

Adagio Medical Holdings (ADGM) has 1 years of Debt to Equity data on file, last reported at -$0.01 in Q4 2023.

  • Quarterly Debt to Equity changed N/A year-over-year to -$0.01 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$0.01 (changed N/A YoY) and the FY2023 annual result came in at -$0.01, changed N/A from the prior year.
  • Debt to Equity held at -$0.01 in Q4 2023 per ADGM's latest filing.
  • Across five years, Debt to Equity topped out at -$0.01 in Q4 2023 and bottomed at -$0.01 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.65
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.64
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.57
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.42
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.06
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.95
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.27
10 Adagio Medical Holdings 16.86 Mn 3.95 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2023 -0.01